Ir a las transacciones
Salud | TMT

MBI Healthcare Technologies has been acquired by DNV AS

January 2023 — The founders of MBI Healthcare Technologies have sold the company to DNV AS. The acquisition forms part of DNV’s strategic expansion into the digital health market, where it aims to significantly grow its presence through innovation, acquisitions, and partnerships. DNV and MBI will work to rapidly scale MBI’s solutions in the UK, target growth in international markets and bring new data assurance technologies to the healthcare sector.

MBI Healthcare Technologies supplies healthcare providers with artificial intelligence-backed technology and data quality expertise to reduce patient safety risks, deliver care more efficiently and bring down waiting times for effective treatment. The company tackles the growing challenge of patient data being imprecisely recorded in electronic health record systems. MBI Healthcare Technologies has worked with more than 80 healthcare providers in the UK to improve elective care performance over the past decade. Its LUNA software platform has been used to manage more than 40 million patient pathways, and the company has assessed more than 10 million clinical documents. MBI Healthcare Technologies’ management will continue to lead the company’s growth, supported by an international team of commercial and domain experts from DNV.

Headquartered in Norway, DNV is a global quality assurance and risk management provider. As a trusted voice for many of the world’s most successful organizations, the company uses its knowledge to advance safety and performance, set industry benchmarks, and inspire and invent solutions to tackle global transformations. DNV is structured into six business areas.

Our role in the transaction

Oaklins Cavendish, based in the UK, advised the three founders of MBI Healthcare Technologies, John Bull, Emilios Evangeli and Barry Mulholland, on the acquisition of the firm by global quality assurance and risk management provider DNV.

Partes
“We are absolutely delighted with the outcome of this deal and are excited to be joining DNV. This strategic decision will enable us to further accelerate our long-term growth objectives and showcase our unique LUNA technology. The Oaklins team has achieved an outstanding result for us through their wealth of sector expertise and highly commercial advice and it has been a joy working with them.”

Barry Mulholland

Founding Partner, MBI Healthcare Technologies

Contáctese con el equipo de la transacción

Peter Gray

Socio
Londres, Reino Unido
Oaklins Cavendish

Transacciones relacionadas

Comtax has been acquired by Ryan
Private Equity | Servicios de Soporte Comercial | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Aprenda más
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Salud

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Aprenda más
Nextalia has acquired a majority stake in Witapp
Private Equity | TMT

Nextalia has acquired a majority stake in Witapp

Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.

Aprenda más